androtriol (YC-6)
/ Guangzhou Cellprotek Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 31, 2026
A Phase IIa trial of Androtriol Injection for the Treatment of Acute Ischemic Stroke-a Prospective, Randomized, and Placebo-controlled Study
(ChiCTR)
- P2 | N=46 | Completed | Sponsor: The Army Medical Center of the Chinese People’s Liberation Army; Guangzhou Cellprotek Pharmaceutical CO., Ltd.
New P2 trial • Cardiovascular • Ischemic stroke
1 to 1
Of
1
Go to page
1